{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:11:18Z","timestamp":1792789878055,"version":"4.5.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-18-158-61"],"award-info":[{"award-number":["IRG-18-158-61"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS091448"],"award-info":[{"award-number":["K08NS091448"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014761","name":"Hope Center for Neurological Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.expneurol.2020.113519","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T17:54:39Z","timestamp":1603994079000},"page":"113519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Vincristine- and bortezomib-induced neuropathies \u2013 from bedside to bench and back"],"prefix":"10.1016","volume":"336","author":[{"given":"Stefanie","family":"Geisler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2020.113519_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1634\/theoncologist.7-1-9","article-title":"Development of the proteasome inhibitor PS-341","volume":"7","author":"Adams","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.expneurol.2020.113519_bb0010","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.expneurol.2013.12.020","article-title":"Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model","volume":"253","author":"Al\u00e9","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12640-014-9514-8","article-title":"Toxic effects of bortezomib on primary sensory neurons and Schwann cells of adult mice","volume":"27","author":"Al\u00e9","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuro.2016.05.004","article-title":"Inhibition of the neuronal NF\u03baB pathway attenuates bortezomib-induced neuropathy in a mouse model","volume":"55","author":"Al\u00e9","year":"2016","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-4522(96)00020-6","article-title":"Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans","volume":"73","author":"Aley","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113519_bb0040","doi-asserted-by":"crossref","first-page":"43846","DOI":"10.1038\/srep43846","article-title":"Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12974-019-1622-1","article-title":"Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis","volume":"16","author":"Alrashdi","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2020.113519_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.10099","article-title":"Is the therapeutic application of neurotrophic factors dead?","volume":"51","author":"Apfel","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0060","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1098014","article-title":"Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration","volume":"305","author":"Araki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113519_bb0065","first-page":"1361","article-title":"Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings","volume":"90","author":"Argyriou","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2020.113519_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17460441.2017.1268596","article-title":"The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma","volume":"12","author":"Arkwright","year":"2017","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.expneurol.2020.113519_bb0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00001756-199904060-00013","article-title":"Pain related behaviour during vincristine-induced neuropathy in rats","volume":"10","author":"Authier","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2020.113519_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0161-813X(03)00043-3","article-title":"A new animal model of vincristine-induced nociceptive peripheral neuropathy","volume":"24","author":"Authier","year":"2003","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0085","doi-asserted-by":"crossref","first-page":"146621","DOI":"10.1016\/j.brainres.2019.146621","article-title":"Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy","volume":"1730","author":"Bechakra","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918797042","article-title":"Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain","volume":"14","author":"Bechakra","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0095","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/1078-0432.CCR-15-2618","article-title":"The sphingosine-1-phosphate modulator FTY720 targets multiple myeloma via the CXCR4\/CXCL12 pathway","volume":"23","author":"Beider","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0105","first-page":"421","article-title":"Bortezomib-induced painful neuropathy in patients with multiple myeloma","volume":"17","author":"Bili\u0144ska","year":"2013","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"10.1016\/j.expneurol.2020.113519_bb0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/02841860510030002","article-title":"Bortezomib: a valuable new antineoplastic strategy in multiple myeloma","volume":"44","author":"Blad\u00e9","year":"2005","journal-title":"Acta Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0115","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/srep06370","article-title":"Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice","volume":"4","author":"Boehmerle","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.expneurol.2011.02.019","article-title":"Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline","volume":"229","author":"Boyette-Davis","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/96.2.235","article-title":"Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies","volume":"96","author":"Bradley","year":"1973","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107999","article-title":"Structural and mechanistic regulation of the pro-degenerative NAD hydrolase SARM1","volume":"32","author":"Bratkowski","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1529-8027.2011.00346.x","article-title":"Evaluation of pre-existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model","volume":"16","author":"Bruna","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113154","article-title":"Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy","volume":"325","author":"Bruna","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hon.2391","article-title":"Bortezomib-induced peripheral neuropathy: a genome-wide association study on multiple myeloma patients","volume":"36","author":"Campo","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.expneurol.2010.09.004","article-title":"Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies","volume":"226","author":"Carozzi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12640-009-9114-1","article-title":"Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat","volume":"17","author":"Carozzi","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0160","doi-asserted-by":"crossref","first-page":"e72995","DOI":"10.1371\/journal.pone.0072995","article-title":"Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse","volume":"8","author":"Carozzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113519_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/96.1.69","article-title":"Vincristine neuropathy: clinical and electrophysiological observations","volume":"96","author":"Casey","year":"1973","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jns5.12073","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know","volume":"19","author":"Cavaletti","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2020.113519_bb0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0195","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41598-018-22216-w","article-title":"Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0200","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/brain\/awaa208","article-title":"Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia","volume":"143","author":"Chen","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0205","article-title":"Antibody against tumor necrosis factor-\u03b1 reduces bortezomib-induced allodynia in a rat model","volume":"7","author":"Chiorazzi","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0220","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.1073\/pnas.95.17.9985","article-title":"An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse","volume":"95","author":"Coleman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113519_bb0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(97)81682-4","article-title":"Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice","volume":"774","author":"Contreras","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0230","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fneur.2019.00622","article-title":"A novel sex-dependent target for the treatment of postoperative pain: the NLRP3 inflammasome","volume":"10","author":"Cowie","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0240","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A","article-title":"Evolution of neuropathy and myopathy during intensive vincristine\/corticosteroid chemotherapy for non-hodgkin\u2019s lymphoma","volume":"67","author":"Deangelis","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2020.113519_bb0245","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cdd.2014.164","article-title":"A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration","volume":"22","author":"Di Stefano","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2020.113519_bb0250","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cub.2017.01.070","article-title":"NMN deamidase delays wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo","volume":"27","author":"Di Stefano","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0255","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","article-title":"Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy","volume":"160","author":"DiAntonio","year":"2019","journal-title":"PAIN"},{"key":"10.1016\/j.expneurol.2020.113519_bb0260","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2020.113519_bb0265","first-page":"56","article-title":"Vincristine induced cranial neuropathy","volume":"60","author":"Dixit","year":"2012","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.expneurol.2020.113519_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djz011","article-title":"The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy","author":"Dorsey","year":"2019","journal-title":"J. Natl.Cancer Inst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0280","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jpain.2019.02.007","article-title":"Activation of sphingosine-1-phosphate receptor 1 in the spinal cord produces mechanohypersensitivity through the activation of inflammasome and IL-1\u03b2 pathway","volume":"20","author":"Doyle","year":"2019","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0285","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fonc.2020.00416","article-title":"Inhibition of microRNA-155 reduces neuropathic pain during chemotherapeutic bortezomib via engagement of neuroinflammation","volume":"10","author":"Duan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0290","first-page":"105","article-title":"Poisoning the spindle: serendipity and discovery of the anti-tumor properties of the Vinca alkaloids (Part II)","volume":"44","author":"Duffin","year":"2002","journal-title":"Pharm. Hist."},{"key":"10.1016\/j.expneurol.2020.113519_bb0295","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/bph.14063","article-title":"Characterization of a rat model of bortezomib-induced painful neuropathy","volume":"174","author":"Duggett","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22415","article-title":"The investigation of therapeutic potential of oxytocin and liraglutide on vincristine-induced neuropathy in rats","volume":"34","author":"Erdo\u011fan","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0305","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 Toll\/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113519_bb0310","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nrl.2016.05.008","article-title":"Neuropathic pain in cancer patients treated with bortezomib","volume":"33","author":"Exp\u00f3sito Vizca\u00edno","year":"2018","journal-title":"Neurologia"},{"key":"10.1016\/j.expneurol.2020.113519_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2020.02.012","article-title":"The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease","volume":"63","author":"Figley","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0330","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1200\/JCO.2005.00.554","article-title":"Childhood cancer survival trends in Europe: a EUROCARE Working Group Study","volume":"23","author":"Gatta","year":"2005","journal-title":"JCO"},{"key":"10.1016\/j.expneurol.2020.113519_bb0340","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129920","article-title":"Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program","volume":"4","author":"Geisler","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2020.113519_bb0335","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/aww251","article-title":"Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice","volume":"139","author":"Geisler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0350","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0345","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1084\/jem.20181040","article-title":"Gene therapy targeting SARM1 blocks pathological axon degeneration in mice","volume":"216","author":"Geisler","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0355","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD+ destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113519_bb0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuron.2015.12.023","article-title":"Axon self-destruction: new links among SARM1, MAPKs, and NAD+ metabolism","volume":"89","author":"Gerdts","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113519_bb0365","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10072-010-0475-2","article-title":"Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study","volume":"32","author":"Giannoccaro","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1040-8428(98)00023-7","article-title":"Vincristine revisited","volume":"29","author":"Gidding","year":"1999","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0380","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2015.02.060","article-title":"Absence of SARM1 rescues development and survival of NMNAT2-deficient axons","volume":"10","author":"Gilley","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0385","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.2009.22.5060","article-title":"Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study","volume":"28","author":"Goldsby","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.expneurol.2020.113519_bb0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.410010311","article-title":"Axonal transport disturbances in vincristine-induced peripheral neuropathy","volume":"1","author":"Green","year":"1977","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0395","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","article-title":"Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation","volume":"158","author":"Grenald","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0400","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0022-510X(80)90179-3","article-title":"Early phase of vincristine neuropathy in man","volume":"45","author":"Guiheneuc","year":"1980","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8143754","article-title":"The actions and mechanisms of P2X7R and p38 MAPK activation in mediating bortezomib-induced neuropathic pain","volume":"2020","author":"Guo","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.expneurol.2020.113519_bb0410","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/j.pain.0000000000000862","article-title":"Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats","volume":"158","author":"Hamity","year":"2017","journal-title":"PAIN"},{"key":"10.1016\/j.expneurol.2020.113519_bb0415","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001924","article-title":"Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats","author":"Hamity","year":"2020","journal-title":"Pain."},{"key":"10.1016\/j.expneurol.2020.113519_bb0420","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113519_bb0425","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1038\/sj.onc.1204623","article-title":"The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications","volume":"20","author":"Hideshima","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.expneurol.2020.113519_bb0430","first-page":"3798","article-title":"Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro","volume":"36","author":"Himes","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0435","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/1097-0142(19890815)64:4<801::AID-CNCR2820640406>3.0.CO;2-E","article-title":"Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy","volume":"64","author":"Hirvonen","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2020.113519_bb0440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ilar\/ilt053","article-title":"Rodent models of chemotherapy-induced peripheral neuropathy","volume":"54","author":"H\u00f6ke","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/j.expneurol.2020.113519_bb0445","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00221-006-0499-2","article-title":"Vincristine-induced neuropathy in rat: electrophysiological and histological study","volume":"173","author":"Ja\u2019afer","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0450","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.1900818","article-title":"Unraveling the plastic peripheral neuroimmune interactome","volume":"204","author":"Jain","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0455","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113519_bb0460","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917719804","article-title":"Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain","volume":"13","author":"Jia","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2862-z","article-title":"The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative Sarm1","author":"Jiang","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2020.113519_bb0470","first-page":"1390","article-title":"The vinca alkaloids: a new class of oncolytic agents","volume":"23","author":"Johnson","year":"1963","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0475","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0480","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","article-title":"United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy","volume":"12","author":"Kane","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34507-3","article-title":"Proteomic approach for understanding milder neurotoxicity of carfilzomib against bortezomib","volume":"8","author":"Karademir","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0490","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.07.008","article-title":"The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice","volume":"592","author":"Kiguchi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0495","doi-asserted-by":"crossref","DOI":"10.4097\/kja.19481","article-title":"Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy","author":"Kim","year":"2020","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0500","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1158\/1055-9965.EPI-11-0239","article-title":"Physical, mental, and neurocognitive status and employment outcomes in the childhood cancer survivor study cohort","volume":"20","author":"Kirchhoff","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.expneurol.2020.113519_bb0505","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201912047","article-title":"SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration","volume":"219","author":"Ko","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: Implications for chemotherapy-induced peripheral neuropathy","volume":"37","author":"LaPointe","year":"2013","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0520","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPH.0b013e3181e01584","article-title":"Vincristine-induced vocal cord palsy: case report and review of the literature","volume":"32","author":"Latiff","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0525","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","article-title":"EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy","volume":"12","author":"Lauria","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0530","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jns.12114","article-title":"Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"20","author":"Lavoie Smith","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0535","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/JPR.S224478","article-title":"The antiallodynic effect of nefopam on vincristine-induced neuropathy in mice","volume":"13","author":"Lee","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113140","article-title":"Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: prospects and limitations","volume":"326","author":"Lehmann","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0545","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1159\/000495828","article-title":"Blocking TRPA1 and TNF-\u03b1 signal improves bortezomib-induced neuropathic pain","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.expneurol.2020.113519_bb0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejpn.2017.12.019","article-title":"Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia","volume":"22","author":"Lieber","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0555","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.leukres.2013.09.018","article-title":"Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol","volume":"37","author":"Liew","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0560","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbi.2015.11.004","article-title":"Upregulation of CCL2 via ATF3\/c-Jun interaction mediated the bortezomib-induced peripheral neuropathy","volume":"53","author":"Liu","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2020.113519_bb0565","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2018.01.011","article-title":"Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib","volume":"302","author":"Liu","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0570","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1073\/pnas.1809392115","article-title":"Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0575","doi-asserted-by":"crossref","first-page":"845","DOI":"10.33549\/physiolres.934015","article-title":"Inhibition of TRPA1 and IL-6 signal alleviates neuropathic pain following chemotherapeutic bortezomib","volume":"68","author":"Liu","year":"2019","journal-title":"Physiol. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0580","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1021\/bi953037i","article-title":"Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine","volume":"35","author":"Lobert","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2020.113519_bb0585","doi-asserted-by":"crossref","first-page":"e13399","DOI":"10.1111\/nmo.13399","article-title":"Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats","volume":"30","author":"L\u00f3pez-G\u00f3mez","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.expneurol.2020.113519_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chembiol.2019.11.002","article-title":"Emergence of SARM1 as a potential therapeutic target for wallerian-type diseases","volume":"27","author":"Loring","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115644","article-title":"Identification of the first noncompetitive SARM1 inhibitors","volume":"28","author":"Loring","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.expneurol.2020.113519_bb0600","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919837429","article-title":"Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy","volume":"15","author":"Ludman","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0605","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919850043","article-title":"Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy","volume":"15","author":"Ludman","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0610","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1460-9568.1989.tb00771.x","article-title":"Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve","volume":"1","author":"Lunn","year":"1989","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0615","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nn770","article-title":"Wallerian degeneration of injured axons and synapses is delayed by a Ube4b\/Nmnat chimeric gene","volume":"4","author":"Mack","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0620","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0625","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroscience.2019.12.003","article-title":"Abnormal pain sensation in mice lacking the prokineticin receptor PKR2: interaction of PKR2 with transient receptor potential TRPV1 and TRPA1","volume":"427","author":"Maftei","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113519_bb0630","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/s12885-018-4728-4","article-title":"Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients","volume":"18","author":"Mahmoudpour","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.expneurol.2020.113519_bb0635","first-page":"1439","article-title":"National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons","volume":"24","author":"Majithia","year":"2016","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.expneurol.2020.113519_bb0640","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archneur.55.12.1513","article-title":"Epidermal nerve fiber density: normative reference range and diagnostic efficiency","volume":"55","author":"McArthur","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0645","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"McCarthy","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0655","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0660","first-page":"151","article-title":"CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats","volume":"5","author":"Meregalli","year":"2012","journal-title":"J. Pain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0665","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/cc.27476","article-title":"Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy","volume":"13","author":"Meregalli","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2020.113519_bb0670","first-page":"115","article-title":"Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice","volume":"29","author":"Meregalli","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.expneurol.2020.113519_bb0675","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","article-title":"Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy","volume":"307","author":"Meregalli","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0680","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-018-1270-x","article-title":"High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats","volume":"15","author":"Meregalli","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2020.113519_bb0685","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12974-018-1116-6","article-title":"A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain","volume":"15","author":"Montague","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2020.113519_bb0690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-019-1461-0","article-title":"Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy","volume":"16","author":"Moschetti","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2020.113519_bb0695","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbi.2019.09.012","article-title":"Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: focus on pain and emotional like behavior","volume":"82","author":"Moschetti","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2020.113519_bb0700","first-page":"68","article-title":"Bilateral vocal cord paralysis following treatment with vincristine","volume":"46","author":"Naithani","year":"2009","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.expneurol.2020.113519_bb0705","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude lifetime cohort study","volume":"94","author":"Ness","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.expneurol.2020.113519_bb0710","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1139\/o90-197","article-title":"The discovery of the vinca alkaloids--chemotherapeutic agents against cancer","volume":"68","author":"Noble","year":"1990","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0720","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1172\/JCI71389","article-title":"Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain","volume":"124","author":"Old","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2020.113519_bb0725","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113519_bb0730","first-page":"1499","article-title":"Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class","volume":"36","author":"Owellen","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0735","first-page":"323","article-title":"Clinical and electrophysiological studies in vincristine induced neuropathy","volume":"39","author":"Pal","year":"1999","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0740","first-page":"2813","article-title":"Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib","volume":"23","author":"Peng","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.expneurol.2020.113519_bb0745","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s00415-017-8599-4","article-title":"Severe refractory CIDP: a case series of 10 patients treated with bortezomib","volume":"264","author":"Pitarokoili","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0750","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4161\/cc.7.7.5625","article-title":"Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition","volume":"7","author":"Poruchynsky","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2020.113519_bb0755","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.0525-08.2008","article-title":"Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress","volume":"28","author":"Press","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0760","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134624","article-title":"Notch activation enhances microglial CX3CR1\/P38 MAPK pathway in rats model of vincristine-induced peripheral neuropathy","volume":"715","author":"Qin","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2020.113519_bb0770","doi-asserted-by":"crossref","first-page":"19574","DOI":"10.1074\/jbc.M111.326801","article-title":"Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: key role of Stat3 signaling","volume":"287","author":"Qu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113519_bb0775","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.clinph.2008.08.007","article-title":"Immune-mediated neuropathies in myeloma patients treated with bortezomib","volume":"119","author":"Ravaglia","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0780","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.01.009","article-title":"Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration","volume":"415","author":"Ravula","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2020.113519_bb0785","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0790","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1200\/JCO.2008.18.3087","article-title":"Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy","volume":"27","author":"Richardson","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2014.11.009","article-title":"Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy","volume":"285","author":"Robinson","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113519_bb0800","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brainres.2014.06.013","article-title":"Altered discharges of spinal neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathy","volume":"1574","author":"Robinson","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0805","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2014.05.051","article-title":"Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat","volume":"274","author":"Robinson","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113519_bb0810","first-page":"149","article-title":"Vinca alkaloid-induced cardiovascular autonomic neuropathy","volume":"69","author":"Roca","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb0815","first-page":"583","article-title":"Low-dose vincristine-associated bilateral vocal cord paralysis","volume":"63","author":"Ryan","year":"1999","journal-title":"Conn. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0820","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1529-8027.2010.00287.x","article-title":"Bortezomib-induced inflammatory neuropathy","volume":"15","author":"Saifee","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0825","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.19.4.367","article-title":"Vincristine-induced neuropathy. A clinical study of fifty leukemic patients","volume":"19","author":"Sandler","year":"1969","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0830","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.5469-08.2009","article-title":"Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide","volume":"29","author":"Sasaki","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0835","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19749","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion","volume":"5","author":"Sasaki","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2020.113519_bb0840","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s12185-011-0847-2","article-title":"Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma","volume":"93","author":"Schmitt","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0845","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0850","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1523\/JNEUROSCI.22-08-03052.2002","article-title":"The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta","volume":"22","author":"Shamash","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0855","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2015.04.012","article-title":"Exogenous induction of HO-1 alleviates vincristine-induced neuropathic pain by reducing spinal glial activation in mice","volume":"79","author":"Shen","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2020.113519_bb0860","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/s0102-865020180060000003","article-title":"Interleukin-4 protects from chemotherapy-induced peripheral neuropathy in mice modal via the stimulation of IL-4\/STAT6 signaling","volume":"33","author":"Shi","year":"2018","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.expneurol.2020.113519_bb0865","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1213\/01.ane.0000204318.35194.ed","article-title":"Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy","volume":"102","author":"Siau","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.expneurol.2020.113519_bb0870","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0875","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1529-8027.2006.0090.x","article-title":"Evidence for direct axonal toxicity in vincristine neuropathy","volume":"11","author":"Silva","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0880","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0000000000000621","article-title":"Therapeutic opportunities and pitfalls in the treatment of axon degeneration","volume":"31","author":"Simon","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0885","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cell.2016.01.032","article-title":"Axon degeneration gated by retrograde activation of somatic pro-apoptotic signaling","volume":"164","author":"Simon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113519_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.100670","article-title":"Sphingosine-1-phosphate signaling: a novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain","volume":"75","author":"Singh","year":"2020","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.expneurol.2020.113519_bb0895","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/acschemneuro.9b00206","article-title":"Bergapten ameliorates vincristine-induced peripheral neuropathy by inhibition of inflammatory cytokines and NF\u03baB signaling","volume":"10","author":"Singh","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0900","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/0008-5472.CAN-15-3116","article-title":"Structural basis for induction of peripheral neuropathy by microtubule-targeting cancer drugs","volume":"76","author":"Smith","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0905","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1016\/j.jmb.2019.06.030","article-title":"Structural evidence for an octameric ring arrangement of SARM1","volume":"431","author":"Sporny","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0910","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuro.2013.09.001","article-title":"Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons","volume":"39","author":"Staff","year":"2013","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0915","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fnins.2019.00653","article-title":"Minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy","volume":"13","author":"Starobova","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0920","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpain.2019.06.008","article-title":"Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin, and oxaliplatin in C57BL\/6J mice","volume":"21","author":"Starobova","year":"2020","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0925","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2020.113519_bb0930","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/j.pain.0000000000001697","article-title":"Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents","volume":"161","author":"Stockstill","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb0935","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10286-012-0164-8","article-title":"Bortezomib-induced severe autonomic neuropathy","volume":"22","author":"Stratogianni","year":"2012","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0940","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clon.2005.12.008","article-title":"An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomib","volume":"18","author":"Stubblefield","year":"2006","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"10.1016\/j.expneurol.2020.113519_bb0945","doi-asserted-by":"crossref","first-page":"E8746","DOI":"10.1073\/pnas.1806933115","article-title":"Palmitoylation enables MAPK-dependent proteostasis of axon survival factors","volume":"115","author":"Summers","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0950","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<481::AID-CNE5>3.0.CO;2-Y","article-title":"Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat","volume":"395","author":"Tanner","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0955","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s12031-013-0095-4","article-title":"Structural and molecular alterations of primary afferent fibres in the spinal dorsal horn in vincristine-induced neuropathy in rat","volume":"51","author":"Thibault","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb0960","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2018.12.003","article-title":"Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice","volume":"413","author":"Tomita","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0965","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1096-9861(20000904)424:4<563::AID-CNE1>3.0.CO;2-U","article-title":"Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat","volume":"424","author":"Topp","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb0975","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1158\/0008-5472.CAN-12-4370","article-title":"Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade","volume":"73","author":"Trevisan","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb0980","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jns.12219","article-title":"Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy","volume":"22","author":"Turkiew","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2020.113519_bb0985","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2146\/ajhp070272","article-title":"Bortezomib: a novel chemotherapeutic agent for hematologic malignancies","volume":"65","author":"Utecht","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.expneurol.2020.113519_bb0990","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.WNL.0000154642.45474.28","article-title":"Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening","volume":"64","author":"Verstappen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113519_bb0995","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1523\/JNEUROSCI.2939-10.2010","article-title":"Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway","volume":"30","author":"Vohra","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113519_bb1000","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","article-title":"Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial","volume":"14","author":"Vora","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.expneurol.2020.113519_bb1005","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/j.pain.0000000000001177","article-title":"Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms","volume":"159","author":"Wahlman","year":"2018","journal-title":"PAIN"},{"key":"10.1016\/j.expneurol.2020.113519_bb1010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnen\/59.7.599","article-title":"Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy","volume":"59","author":"Wang","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb1015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.10039","article-title":"The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy","volume":"50","author":"Wang","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113519_bb1020","first-page":"977","article-title":"Inhibition of PAR2 and TRPA1 signals alleviates neuropathic pain evoked by chemotherapeutic bortezomib","volume":"31","author":"Wang","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.expneurol.2020.113519_bb1025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.celrep.2018.03.071","article-title":"Sarm1\/Myd88-5 regulates neuronal intrinsic immune response to traumatic axonal injuries","volume":"23","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113519_bb1030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpainsymman.2019.06.018","article-title":"Minocycline for symptom reduction during oxaliplatin-based chemotherapy for colorectal cancer: a phase II randomized clinical trial","volume":"58","author":"Wang","year":"2019","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.expneurol.2020.113519_bb1035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3959(02)00445-1","article-title":"Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia","volume":"103","author":"Weng","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2020.113519_bb1040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.scr.2017.06.006","article-title":"Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy","volume":"22","author":"Wing","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb1045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gaitpost.2017.05.004","article-title":"Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia","volume":"58","author":"Wright","year":"2017","journal-title":"Gait Posture"},{"key":"10.1016\/j.expneurol.2020.113519_bb1050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.pain.2013.02.027","article-title":"Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia","volume":"154","author":"Xie","year":"2013","journal-title":"PAIN"},{"key":"10.1016\/j.expneurol.2020.113519_bb1055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuroscience.2015.02.010","article-title":"Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain","volume":"291","author":"Xie","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113519_bb1060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neuropharm.2017.06.027","article-title":"Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord","volume":"123","author":"Xie","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2020.113519_bb1065","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.1074\/jbc.M113.450049","article-title":"G-protein-coupled receptor agonist BV8\/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells","volume":"288","author":"Xin","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113519_bb1070","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.12998\/wjcc.v7.i18.2905","article-title":"Guillain-Barr\u00e9 syndrome in a patient with multiple myeloma after bortezomib therapy: a case report","volume":"7","author":"Xu","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.expneurol.2020.113519_bb1075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jphs.2015.08.006","article-title":"Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats","volume":"129","author":"Yamamoto","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb1080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/16078454.2020.1784615","article-title":"The effect of rat nerve growth factor combined with vitamin B on peripheral neuropathy in multiple myeloma patients","volume":"25","author":"Yan","year":"2020","journal-title":"Hematology"},{"key":"10.1016\/j.expneurol.2020.113519_bb1085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2014.11.053","article-title":"Pathological axonal death through a MAPK cascade that triggers a local energy deficit","volume":"160","author":"Yang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113519_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183491","article-title":"Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies","volume":"12","author":"Youk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113519_bb1095","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2020.113519_bb1100","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3109\/10428194.2013.873535","article-title":"Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score","volume":"55","author":"Zaroulis","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.expneurol.2020.113519_bb1105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbi.2014.01.020","article-title":"TNF-\u03b1-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy","volume":"38","author":"Zhang","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2020.113519_bb1110","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00018-017-2513-1","article-title":"Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain","volume":"74","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2020.113519_bb1115","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00277-019-03816-6","article-title":"Peripheral neuropathy following bortezomib therapy in multiple myeloma patients: association with cumulative dose, heparanase, and TNF-\u03b1","volume":"98","author":"Zhao","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.expneurol.2020.113519_bb1120","series-title":"Progress in Molecular Biology and Translational Science","first-page":"149","article-title":"Prokineticins and their G protein-coupled receptors in health and disease","author":"Zhao","year":"2019"},{"key":"10.1016\/j.expneurol.2020.113519_bb1125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-ribose and induce non-apoptotic cell death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2020.113519_bb1130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2018.03.004","article-title":"Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1\/CXCR2 signaling pathway","volume":"135","author":"Zhou","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2020.113519_bb1135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.phrs.2018.07.002","article-title":"Minocycline as a promising therapeutic strategy for chronic pain","volume":"134","author":"Zhou","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2020.113519_bb1140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s13311-019-00784-7","article-title":"Levo-corydalmine attenuates vincristine-induced neuropathic pain in mice by upregulating the Nrf2\/HO-1\/CO pathway to inhibit connexin 43 expression","volume":"17","author":"Zhou","year":"2020","journal-title":"Neurotherapeutics"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620303502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620303502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:52:18Z","timestamp":1762149138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620303502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":218,"alternative-id":["S0014488620303502"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113519","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vincristine- and bortezomib-induced neuropathies \u2013 from bedside to bench and back","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113519"}}